<DOC>
	<DOCNO>NCT00080288</DOCNO>
	<brief_summary>The primary objective study determine whether treatment Armodafinil ( CEP-10953 ) effective placebo treatment patient excessive sleepiness associate chronic shift work sleep disorder ( SWSD ) measure mean sleep latency Multiple Sleep Latency Test ( MSLT ) ( 20 minute ) ( average 4 naps 0200 , 0400 , 0600 , 0800 ) Clinical Global Impression Change ( CGI-C ) rating .</brief_summary>
	<brief_title>Safety/Efficacy Study With Armodafinil ( CEP-10953 ) Treatment Excessive Sleepiness Associated With Chronic SWSD</brief_title>
	<detailed_description />
	<mesh_term>Sleep Wake Disorders</mesh_term>
	<mesh_term>Parasomnias</mesh_term>
	<mesh_term>Disorders Excessive Somnolence</mesh_term>
	<mesh_term>Sleep Disorders , Circadian Rhythm</mesh_term>
	<mesh_term>Armodafinil</mesh_term>
	<mesh_term>Modafinil</mesh_term>
	<criteria>Patients include study follow criterion meet : Written inform consent obtain . The patient outpatient , man woman ethnic origin , 18 65 year age ( inclusive ) . The patient complaint excessive sleepiness . The patient diagnosis SWSD accord International Classification Sleep Disorders ( ICSD ) criterion , must excessive sleepiness night shift least 3 month . The patient must work least 5 night shift per month , least 3 night consecutive , plan maintain schedule . The patient must work night shift include least 6 hour 2200 0800 long 12 hour duration . The patient good health determine medical psychiatric history , physical examination , ECG , serum chemistry hematology . Women must surgically sterile , 2 year postmenopausal , , childbearing potential , use medically accept method birth control ( ie , barrier method spermicide , steroidal contraceptive , intrauterine device [ IUD ] ) agree continue use method duration study . Steroidal contraceptives must use barrier method take study drug least full cycle discontinuation study drug . The patient mean sleep latency 6 minute less determined MSLT The patient CGIS rating pertains sleepiness night shift include commute work . The patient medical psychiatric disorder could account excessive sleepiness night shift . The patient able complete self rating scale computerbased test . The patient willing able comply study restriction attend regularly schedule clinic visit specify protocol . Patients exclude participate study 1 follow criterion meet : clinically significant , uncontrolled medical psychiatric condition ( treat untreated ) probable diagnosis current sleep disorder SWSD consume caffeine include coffee , tea and/or caffeine contain beverage food average 600 mg caffeine per day use prescription drug disallow protocol clinically significant use thecounter ( OTC ) drug within 7 day screening/baseline visit history alcohol , narcotic , drug abuse define Diagnostic Statistical Manual Mental Disorders American Psychiatric Association , 4th Edition ( DSM IV ) positive urine drug screen ( UDS ) screen visit clinically significant deviation normal physical examination pregnant lactate woman . ( Any woman become pregnant study withdrawn study . ) use investigational drug within 1 month screen visit disorder may interfere drug absorption , distribution , metabolism , excretion ( include gastrointestinal surgery ) know clinically significant drug sensitivity stimulant modafinil</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Excessive Sleepiness</keyword>
	<keyword>Chronic Shift Work Sleep Disorder</keyword>
	<keyword>Chronic SWSD</keyword>
	<keyword>Circadian Rhythm Disorder</keyword>
	<keyword>Shift Worker</keyword>
	<keyword>Cephalon</keyword>
	<keyword>Cephalon , Inc</keyword>
	<keyword>Nuvigil</keyword>
</DOC>